Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study.

V.K. Dik; H.B. Bueno de Mesquita; M.G.H. van Oijen; P.D. Siersema; C.S.P.M. Uiterwaal; C.H. van Gils; F.J.B van Duijnhoven; S. Cauchi; L. Yengo; P. Froguel; K. Overvad; B.H. Bech; A. Tjonneland; A. Olsen; M.C. Boutron-Ruault; A. Racine; G. Fagherazzi; H. Boeing; K. Aleksandrova; D. Palli; P. Vineis; S. Panico; P.H.M. Peeters; X et al; E. Riboli

doi:10.1002/ijc.28655.

Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study.

V.K. Dik, H.B. Bueno de Mesquita, M.G.H. van Oijen, P.D. Siersema, C.S.P.M. Uiterwaal, C.H. van Gils, F.J.B van Duijnhoven, S. Cauchi, L. Yengo, P. Froguel, K. Overvad, B.H. Bech, A. Tjonneland, A. Olsen, M.C. Boutron-Ruault, A. Racine, G. Fagherazzi, H. Boeing, K. Aleksandrova, D. PalliP. Vineis, S. Panico, P.H.M. Peeters, X et al, E. Riboli

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	401-412
Number of pages	12
Journal	International Journal of Cancer
Volume	135
Issue number	2
DOIs	https://doi.org/10.1002/ijc.28655.
Publication status	Published - 2014

Access to Document

10.1002/ijc.28655.

http://www.ncbi.nlm.nih.gov/pubmed/24318358

Cite this

Dik, V. K., Bueno de Mesquita, H. B., van Oijen, M. G. H., Siersema, P. D., Uiterwaal, C. S. P. M., van Gils, C. H., van Duijnhoven, F. J. B., Cauchi, S., Yengo, L., Froguel, P., Overvad, K., Bech, B. H., Tjonneland, A., Olsen, A., Boutron-Ruault, M. C., Racine, A., Fagherazzi, G., Boeing, H., Aleksandrova, K., ... Riboli, E. (2014). Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study. International Journal of Cancer, 135(2), 401-412. https://doi.org/10.1002/ijc.28655.

@article{2093dcbf44d3490394cce6672a5e7086,

title = "Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study.",

author = "V.K. Dik and \{Bueno de Mesquita\}, H.B. and \{van Oijen\}, M.G.H. and P.D. Siersema and C.S.P.M. Uiterwaal and \{van Gils\}, C.H. and \{van Duijnhoven\}, F.J.B and S. Cauchi and L. Yengo and P. Froguel and K. Overvad and B.H. Bech and A. Tjonneland and A. Olsen and M.C. Boutron-Ruault and A. Racine and G. Fagherazzi and H. Boeing and K. Aleksandrova and D. Palli and P. Vineis and S. Panico and P.H.M. Peeters and \{et al\}, X and E. Riboli",

year = "2014",

doi = "10.1002/ijc.28655.",

language = "English",

volume = "135",

pages = "401--412",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley \& Sons Inc.",

number = "2",

}

Dik, VK, Bueno de Mesquita, HB, van Oijen, MGH, Siersema, PD, Uiterwaal, CSPM, van Gils, CH, van Duijnhoven, FJB, Cauchi, S, Yengo, L, Froguel, P, Overvad, K, Bech, BH, Tjonneland, A, Olsen, A, Boutron-Ruault, MC, Racine, A, Fagherazzi, G, Boeing, H, Aleksandrova, K, Palli, D, Vineis, P, Panico, S, Peeters, PHM, et al, X & Riboli, E 2014, 'Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study.', International Journal of Cancer, vol. 135, no. 2, pp. 401-412. https://doi.org/10.1002/ijc.28655.

TY - JOUR

T1 - Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study.

AU - Dik, V.K.

AU - Bueno de Mesquita, H.B.

AU - van Oijen, M.G.H.

AU - Siersema, P.D.

AU - Uiterwaal, C.S.P.M.

AU - van Gils, C.H.

AU - van Duijnhoven, F.J.B

AU - Cauchi, S.

AU - Yengo, L.

AU - Froguel, P.

AU - Overvad, K.

AU - Bech, B.H.

AU - Tjonneland, A.

AU - Olsen, A.

AU - Boutron-Ruault, M.C.

AU - Racine, A.

AU - Fagherazzi, G.

AU - Boeing, H.

AU - Aleksandrova, K.

AU - Palli, D.

AU - Vineis, P.

AU - Panico, S.

AU - Peeters, P.H.M.

AU - et al, X

AU - Riboli, E.

PY - 2014

Y1 - 2014

U2 - 10.1002/ijc.28655.

DO - 10.1002/ijc.28655.

M3 - Article

SN - 0020-7136

VL - 135

SP - 401

EP - 412

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 2

ER -